Skip to content

Continuous Labor Epidural Catheter for Tubal Ligation Study

Success Rate, Efficiency, and Predictors of Reactivation of a Continuous Labor Epidural Catheter for Postpartum Tubal Ligation

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00898443
Enrollment
18
Registered
2009-05-12
Start date
2008-10-31
Completion date
2010-08-31
Last updated
2012-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tubal Ligation, Bilateral Tubal Ligation

Brief summary

This study is to study the success rate of using the epidural catheter that was placed during the labor for the surgical anesthesia to perform a postpartum tubal ligation.

Interventions

OTHEREpidural anesthetic

Use of the existing continuous labor epidural for surgical anesthetic for postpartum tubal ligation

This group was assigned to receive spinal anesthetic for postpartum tubal ligation.

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) 1-3 postpartum women desiring Postpartum Bilateral Tubal Ligation (PPBTL) for infertility * Functional epidural catheter placed for labor and delivery analgesia * The epidural is still taped within 1cm of the original depth when it was functional for labor analgesia * 1-45 years of age

Exclusion criteria

* ASA 4 status * History of dural puncture (wet tap) during initial epidural catheter insertion * History of marginal or inadequate epidural analgesia for labor * Cesarean section for delivery * Examination demonstrates that the indwelling catheter has migrated more than 1 cm from the original depth when secured * The end of indwelling epidural catheter appears to have not been capped appropriately or the cap was not maintained intact * Prolonged sensory or motor block, bladder or anal sphincter dysfunction, nerve damage, inability to ambulate, post-dural puncture headache (PDHD), or seizures, during or after delivery and following cessation of the epidural catheter dosing * Pseudocholinesterase deficiency * Allergy to Nesacaine® (chloroprocaine) or lidocaine * General anesthesia provided for delivery * History of substance abuse disorder * History of major psychiatric disorder * Non-English reading/speaking participants

Design outcomes

Primary

MeasureTime frameDescription
Success Rate of Reactivation of Existing Continuous Labor Epidural Catheter for Postpartum Tubal Ligationat the time of surgeryRate of reactivation of the epidural catheter for postpartum tubal ligation in the group that was randomized to the epidural anesthetic group. (Need for additional supplemental analgesics and sedatives or the need to convert to general anesthesia.)

Secondary

MeasureTime frameDescription
Impact of Anesthesia Type on OR (Operating Room) Efficiencyminutes until surgery startThe time minutes)from initiation of anesthesia to surgery start.

Countries

United States

Participant flow

Recruitment details

Women in labor, admitted to UAB Labor & Delivery, who requested postpartum tubal ligation after delivery.

Participants by arm

ArmCount
Spinal Anesthetic Group
This group will receive spinal anesthetic for the surgical procedure and will serve as the control group for this study.
9
Epidural Anesthetic Group
This is the experimental group for this study.
8
Total17

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicSpinal Anesthetic GroupEpidural Anesthetic GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants8 Participants17 Participants
Region of Enrollment
United States
9 participants8 participants17 participants
Sex: Female, Male
Female
9 Participants8 Participants17 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 90 / 8
serious
Total, serious adverse events
0 / 90 / 8

Outcome results

Primary

Success Rate of Reactivation of Existing Continuous Labor Epidural Catheter for Postpartum Tubal Ligation

Rate of reactivation of the epidural catheter for postpartum tubal ligation in the group that was randomized to the epidural anesthetic group. (Need for additional supplemental analgesics and sedatives or the need to convert to general anesthesia.)

Time frame: at the time of surgery

Population: Only the patients who were recruited, randomized and had all their data completed at the time of their procedure were included in the analysis. Insufficient numbers were recruited to complete the study as designed.

ArmMeasureValue (NUMBER)Dispersion
Spinal Anesthetic GroupSuccess Rate of Reactivation of Existing Continuous Labor Epidural Catheter for Postpartum Tubal Ligation0 participants 0
Epidural Anesthetic GroupSuccess Rate of Reactivation of Existing Continuous Labor Epidural Catheter for Postpartum Tubal Ligation7 participants 0
Secondary

Impact of Anesthesia Type on OR (Operating Room) Efficiency

The time minutes)from initiation of anesthesia to surgery start.

Time frame: minutes until surgery start

Population: Only the patients who were recruited, randomized and had all their data completed at the time of their procedure were included in the analysis. Insufficient numbers were recruited to complete the study as designed.

ArmMeasureValue (MEDIAN)
Spinal Anesthetic GroupImpact of Anesthesia Type on OR (Operating Room) Efficiency14 minutes
Epidural Anesthetic GroupImpact of Anesthesia Type on OR (Operating Room) Efficiency29 minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026